Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel proteasome inhibitor ER807446 demonstrates antitumor activity especially against large tumors

April 29, 2004

ViRexx Medical receives grant to fund phase I trial of Occlusin

April 28, 2004

Phase III trial of Tarceva in NSCLC meets endpoints

April 28, 2004

Genmab licenses GT43 cancer target from Ganymed

April 28, 2004

CV Therapeutics describes adenosine A3 agonists for cancer and neutropenia therapy

April 28, 2004

Novel BH3-derived proapoptotic peptides developed by Dana Farber researchers

April 28, 2004

New data on Fujisawa's histone deacetylase inhibitor FR-901228

April 28, 2004

Novel cytotoxic agent effective against chemotherapy-resistant ovarian carcinoma

April 28, 2004

Synthetic truncated PSP94 for metastatic hormone-resistant prostate cancer patients

April 28, 2004

Preclinical studies shed light on molecular pathways of p53

April 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...